Retraction

MiR-29a Function as Tumor Suppressor in Cervical Cancer by Targeting SIRT1 and Predict Patient Prognosis

Citations (24)

24
Total Citations
1
Post-Retraction
(4.2%)
23
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
1 Within 1 year
0 After 2+ years
362 Days since retraction (latest)
MicroRNAs and human viral diseases: A focus on the role of microRNA-29
Mina Mobini Kesheh, Mobina Bayat, Sepehr Kobravi et al. (14 authors)
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Published: Sep 2024
6 citations
362 days after retraction
Comparison of Oncogenes, Tumor Suppressors, and MicroRNAs Between Schizophrenia and Glioma: The Balance of Power
James S. Brown
Neuroscience & Biobehavioral Reviews
Published: May 2023
4 citations
126 days before retraction
miR-221-3p Modulates Cervical Cancer Cells Proliferation and Invasion After Co-Culture with Bone Marrow Mesenchymal Stem Cells (BMSCs)
Hongyan Cheng, Tao Jiang
Journal of Biomaterials and Tissue Engineering
Published: May 2023
136 days before retraction
MiR-29a-3p: a potential biomarker and therapeutic target in colorectal cancer
Wenyan Mo, Shi-Qiong Cao
Clinical & Translational Oncology Open Access
Published: Nov 2022
26 citations
308 days before retraction
Circ_0072995 drives cervical cancer development by regulating the miR-29a/WDR5 axis
Zhenzhen Song, Hongyu Li
Journal of Obstetrics and Gynaecology
Published: Sep 2022
2 citations
351 days before retraction
Small biomarkers with massive impacts: PI3K/AKT/mTOR signalling and microRNA crosstalk regulate nasopharyngeal carcinoma
Hailong Li, Nian-Hua Deng, HE Xiu-sheng et al. (4 authors)
Biomarker Research Open Access
Published: Jul 2022
30 citations
415 days before retraction
Therapeutic potential of anti-miR29a in breast cancer patients with type 2 diabetes: an in vitro and xenograft mouse-model study
Zhihua Li, Liangliang Min, Lu Chen et al. (8 authors)
Translational Cancer Research Open Access
Published: May 2022
1 citation
501 days before retraction
Upregulation of miR-34a-5p, miR-20a-3p and miR-29a-3p by Onconase in A375 Melanoma Cells Correlates with the Downregulation of Specific Onco-Proteins
Elisa De Tomi, Rachele Campagnari, Elisa Orlandi et al. (8 authors)
International Journal of Molecular Sciences Open Access
Published: Jan 2022
8 citations
591 days before retraction
Epigenetics in Cancer Biology
Richard A. Stein, Abhi N. Deverakonda
Unknown Journal
Published: Jan 2022
621 days before retraction
Cervical Cancer, Papillomavirus, and miRNA Dysfunction
Evelyn Gabriela Bañuelos-Villegas, María Fernanda Pérez-yPérez, Luis Marat Álvarez-Salas
Frontiers in Molecular Biosciences Open Access
Published: Dec 2021
45 citations
643 days before retraction
Extracellular Vesicles Long Non-Coding RNA AGAP2-AS1 Contributes to Cervical Cancer Cell Proliferation Through Regulating the miR-3064-5p/SIRT1 Axis
Li Min, Jing Wang, Hongli Ma et al. (6 authors)
Frontiers in Oncology Open Access
Published: Nov 2021
12 citations
681 days before retraction
Therapeutic Potential of miR-29a in Breast Cancer Patients with type 2 Diabetes and its Regulatory Mechanism
Zhihua Li, Yangyang Hu, Wenjing Luan et al. (8 authors)
Research Square (Research Square) Open Access
Published: Sep 2021
1 citation
742 days before retraction
Small Non-Coding-RNA in Gynecological Malignancies
Shailendra Kumar Dhar Dwivedi, Geeta Rao, Anindya Dey et al. (6 authors)
Cancers Open Access
Published: Mar 2021
34 citations
925 days before retraction
Prognostic value of miR‑339‑5p in patients with prostate cancer and its effects on tumor progression
Huafeng Pan, Rui Xin, Wei Wei et al. (5 authors)
Experimental and Therapeutic Medicine Open Access
Published: Feb 2021
5 citations
932 days before retraction
SIRT1 and gynecological malignancies (Review)
Jiayu Chen, Hou‐Zao Chen, Lingya Pan
Oncology Reports Open Access
Published: Feb 2021
26 citations
932 days before retraction
MicroRNA‑29a inhibits cell proliferation and arrests cell cycle by modulating p16 methylation in cervical cancer
Anjin Wang, Qiying Xu, Sha Rengaowa et al. (6 authors)
Oncology Letters Open Access
Published: Feb 2021
23 citations
947 days before retraction
Peer Review #1 of "miR-29a-3p directly targets Smad nuclear interacting protein 1 and inhibits the migration and proliferation of cervical cancer HeLa cells (v0.1)"
Ying Chen, Weiji Zhang, Jun Li et al. (10 authors)
Unknown Journal Open Access
Published: Oct 2020
1059 days before retraction
miR-29a-3p directly targets Smad nuclear interacting protein 1 and inhibits the migration and proliferation of cervical cancer HeLa cells
Ying Chen, Weiji Zhang, Lijun Yan et al. (5 authors)
PeerJ Open Access
Published: Oct 2020
26 citations
1059 days before retraction
Peer Review #2 of "miR-29a-3p directly targets Smad nuclear interacting protein 1 and inhibits the migration and proliferation of cervical cancer HeLa cells (v0.1)"
Ying Chen, Weiji Zhang, Jun Li et al. (10 authors)
Unknown Journal Open Access
Published: Oct 2020
1059 days before retraction
miR-29a Modulates GSK3β/SIRT1-Linked Mitochondrial Proteostatic Stress to Ameliorate Mouse Non-Alcoholic Steatohepatitis
Ya‐Ling Yang, Pei‐Wen Wang, Feng‐Sheng Wang et al. (5 authors)
International Journal of Molecular Sciences Open Access
Published: Sep 2020
30 citations
1090 days before retraction
Increased miR-20b Level in High Grade Cervical Intraepithelial Neoplasia
Tímea Szekerczés, Ádám Galamb, Norbert Varga et al. (12 authors)
Pathology & Oncology Research Open Access
Published: Jul 2020
8 citations
1163 days before retraction
MicroRNAs in cancer therapy: Their involvement in oxaliplatin sensitivity/resistance of cancer cells with a focus on colorectal cancer
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi et al. (7 authors)
Life Sciences
Published: Jun 2020
30 citations
1181 days before retraction
MAPK-induced miR-29 targets MAFG and suppresses melanoma development
Olga Vera, Ilah Bok, Neel Jasani et al. (10 authors)
bioRxiv (Cold Spring Harbor Laboratory) Open Access
Published: Jan 2020
1325 days before retraction
Quick Stats
Total Citations: 24
Years Since Retraction: 2.2 years
Open Access: Yes
Last Checked: Jul 24, 2025